MP77-12 IMPACT OF INCREASED EXPRESSION OF BOTH RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1 AND P21-ACTIVATED KINASE 1 IN PATIENTS WITH N0M0 UPPER URINARY TRACT UROTHELIAL CARCINOMA